NIU restriction and item codes
Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
PBS NIU restriction and item codes
Contact Details
PBS Complex Drugs Programs
Forms
Non-infectious uveitis - adalimumab - initial authority application (PB372)
Services Australia website
Non-infectious uveitis
FAQs from Service Officers
Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.
Item | Description |
1 | Can increased quantity and or/repeats be authorised for adalimumab for NIU? No increase in quantity and/or repeats (NO INC) is allowed for all NIU listings except for balance of supply listings where no increase in quantity (NO Q INC) is allowed. |
2 | How to enter the dosing of quantity 2 and repeat 6 in the Online PBS Authorities (OPA) system for the initial or recommencing authority approvals for NIU? If a loading dose regimen is indicated (for example, '80mg week 0 followed by 40mg fortnightly' or 'dosing as directed'), record the dose as '1' and the dose frequency 'as required' in the OPA system. |
3 | If you receive an initial or recommencement request where a loading dose is not intended (i.e. dose indicated as one injection fortnightly), how many repeats are you able to approve? Service Officers can only approve 5 repeats to allow for 24 weeks of treatment which does not exceed the maximum amount of 25 weeks under this restriction. |
Expand all